UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
FORM 10-Q
(Mark One)
| [ü] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
OR
| [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Commission file number 0-26844
RADISYS CORPORATION
| OREGON | 93-0945232 | |
| (State or other jurisdiction of | (I.R.S. Employer | |
| Incorporation or Organization) | Identification Number) |
5445 N.E. Dawson Creek Drive
Hillsboro, OR 97124
(Address of principal executive offices, including zip code)
(503) 615-1100
(Registrants telephone number, including area code)
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to the filing requirements for the past 90 days. Yes [ü] No [ ]
Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Act) Yes [ü] No [ ]
Number of shares of Common Stock outstanding as of August 2, 2004: 18,943,364
RADISYS CORPORATION
FORM 10-Q
TABLE OF CONTENTS
| Page |
||||||||
| 2 | ||||||||
| 3 | ||||||||
| 4 | ||||||||
| 5 | ||||||||
| 6 | ||||||||
| 21 | ||||||||
| 42 | ||||||||
| 43 | ||||||||
| 44 | ||||||||
| 46 | ||||||||
| 47 | ||||||||
| EXHIBIT 10.1 | ||||||||
| EXHIBIT 31.1 | ||||||||
| EXHIBIT 31.2 | ||||||||
| EXHIBIT 32.1 | ||||||||
| EXHIBIT 32.2 | ||||||||
1
PART I. FINANCIAL INFORMATION
Item 1. Consolidated Financial Statements
RADISYS CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share amounts, unaudited)
| For the Three Months Ended | For the Six Months Ended | |||||||||||||||
| June 30, |
June 30, |
|||||||||||||||
| 2004 |
2003 |
2004 |
2003 |
|||||||||||||
Revenues |
$ | 60,253 | $ | 48,898 | $ | 121,368 | $ | 97,302 | ||||||||
Cost of sales |
40,231 | 32,945 | 82,528 | 66,152 | ||||||||||||
Gross margin |
20,022 | 15,953 | 38,840 | 31,150 | ||||||||||||
Research and development |
7,135 | 5,733 | 13,479 | 11,273 | ||||||||||||
Selling, general, and administrative |
7,684 | 6,783 | 15,361 | 13,331 | ||||||||||||
Intangible assets amortization |
515 | 765 | 1,197 | 1,530 | ||||||||||||
Restructuring (reversals) charges |
(678 | ) | | (858 | ) | 1,829 | ||||||||||
Income from operations |
5,366 | 2,672 | 9,661 | 3,187 | ||||||||||||
(Loss) gain on repurchase of convertible
subordinated notes |
(387 | ) | | (387 | ) | 825 | ||||||||||
Interest expense |
(1,049 | ) | (1,151 | ) | (2,475 | ) | (2,360 | ) | ||||||||
Interest income |
772 | 556 | 1,628 | 1,359 | ||||||||||||
Other (expense) income, net |
(27 | ) | (297 | ) | 51 | (789 | ) | |||||||||
Income from continuing operations before income
tax provision |
4,675 | 1,780 | 8,478 | 2,222 | ||||||||||||
Income tax provision (benefit) |
1,168 | (9 | ) | 2,123 | | |||||||||||
Income from continuing operations |
3,507 | 1,789 | 6,355 | 2,222 | ||||||||||||
Discontinued operations related to Savvi business: |
||||||||||||||||
Loss from discontinued operations |
| | | (4,679 | ) | |||||||||||
Net income (loss) |
$ | 3,507 | $ | 1,789 | $ | 6,355 | $ | (2,457 | ) | |||||||
Income per share from continuing operations: |
||||||||||||||||
Basic |
$ | 0.19 | $ | 0.10 | $ | 0.34 | $ | 0.13 | ||||||||
Diluted |
$ | 0.18 | $ | 0.10 | $ | 0.33 | $ | 0.12 | ||||||||
Net income (loss) per share: |
||||||||||||||||
Basic |
$ | 0.19 | $ | 0.10 | $ | 0.34 | $ | (0.14 | ) | |||||||
Diluted |
$ | 0.18 | $ | 0.10 | $ | 0.33 | $ | (0.14 | ) | |||||||
Weighted average shares outstanding: |
||||||||||||||||
Basic |
18,826 | 17,785 | 18,659 | 17,728 | ||||||||||||
Diluted |
19,590 | 18,098 | 19,522 | 17,967 | ||||||||||||
The accompanying notes are an integral part of these financial statements.
2
RADISYS CORPORATION
CONSOLIDATED BALANCE SHEETS
(In thousands, unaudited)
| June 30, | December 31, | |||||||
| 2004 |
2003 |
|||||||
ASSETS |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ | 119,307 | $ | 149,925 | ||||
Short-term investments, net |
26,201 | 44,456 | ||||||
Accounts receivable, net |
37,845 | 32,098 | ||||||
Other receivables |
2,649 | 49 | ||||||
Inventories, net |
21,796 | 26,092 | ||||||
Other current assets |
2,648 | 2,778 | ||||||
Deferred tax assets |
6,898 | 6,898 | ||||||
Total current assets |
217,344 | 262,296 | ||||||
Property and equipment, net |
14,081 | 14,584 | ||||||
Goodwill |
27,521 | 27,521 | ||||||
Intangible assets, net |
5,240 | 6,437 | ||||||
Long-term investments, net |
35,850 | 30,992 | ||||||
Long-term deferred tax assets |
21,339 | 21,911 | ||||||
Other assets |
2,070 | 1,821 | ||||||
Total assets |
$ | 323,445 | $ | 365,562 | ||||
LIABILITIES AND SHAREHOLDERS EQUITY |
||||||||
Current liabilities: |
||||||||
Accounts payable |
$ | 26,265 | $ | 21,969 | ||||
Accrued wages and bonuses |
5,370 | 4,868 | ||||||
Accrued interest payable |
378 | 1,577 | ||||||
Accrued restructuring |
315 | 2,820 | ||||||
Other accrued liabilities |
8,145 | 8,738 | ||||||
Total current liabilities |
40,473 | 39,972 | ||||||
Long-term liabilities: |
||||||||
Convertible senior notes, net |
97,083 | 97,015 | ||||||
Convertible subordinated notes, net |
9,845 | 67,585 | ||||||
Total long-term liabilities |
106,928 | 164,600 | ||||||
Total liabilities |
147,401 | 204,572 | ||||||
Shareholders equity : |
||||||||
Common stock no par value, 100,000 shares authorized;
18,940 and 18,274 shares issued and outstanding at
June 30, 2004 and December 31, 2003 |
175,511 | 166,445 | ||||||
Accumulated deficit |
(2,339 | ) | (8,694 | ) | ||||
Accumulated other comprehensive income: |
||||||||
Cumulative translation adjustments |
2,872 | 3,239 | ||||||
Total shareholders equity |
176,044 | 160,990 | ||||||
Total liabilities and shareholders equity |
$ | 323,445 | $ | 365,562 | ||||
The accompanying notes are an integral part of these financial statements.
3
RADISYS CORPORATION
CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS EQUITY
(In thousands, unaudited)
| Common Stock |
Cumulative translation |
Accumulated | Total other comprehensive |
|||||||||||||||||||||
| Shares |
Amount |
adjustments(1) |
deficit |
Total |
income (loss) (2) |
|||||||||||||||||||
Balances, December 31, 2003 |
18,274 | $ | 166,445 | $ | 3,239 | $ | (8,694 | ) | $ | 160,990 | ||||||||||||||
Shares issued pursuant to benefit plans |
666 | 6,717 | | | 6,717 | $ | | |||||||||||||||||
Tax benefit of stock-based benefit plans |
| 1,720 | | | 1,720 | | ||||||||||||||||||
Stock-based compensation |
| 629 | | | 629 | | ||||||||||||||||||
Translation adjustments |
| | (367 | ) | | (367 | ) | (367 | ) | |||||||||||||||
Net income for the period |
| | | 6,355 | 6,355 | 6,355 | ||||||||||||||||||
Balances, June 30, 2004 |
18,940 | $ | 175,511 | $ | 2,872 | $ | (2,339 | ) | $ | 176,044 | ||||||||||||||
Comprehensive income, for the six
months ended June 30, 2004 |
$ | 5,988 | ||||||||||||||||||||||
| (1) | Income taxes are not provided for foreign currency translation adjustments. | |
| (2) | For the three months ended June 30, 2004, other comprehensive income amounted to $3.3 million and consisted of the net income for the period of $3.5 million and net losses from translation adjustments of $207 thousand. For the three months ended June 30, 2003, other comprehensive income amounted to $2.4 million and consisted of the net income for the period of $1.8 million, net gains from translation adjustments of $658 thousand, and unrealized loss on a security available for sale of $77 thousand. For the six months ended June 30, 2003, other comprehensive loss amounted to $1.8 million and consisted of the net loss for the period of $2.5 million, net gains from translation adjustments of $730 thousand, and net unrealized loss on securities available for sale of $34 thousand. |
The accompanying notes are an integral part of these financial statements.
4
RADISYS CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands, unaudited)
| For the Six Months Ended June 30, |
||||||||
| 2004 |
2003 |
|||||||
Cash flows from operating activities: |
||||||||
Net income (loss) |
$ | 6,355 | $ | (2,457 | ) | |||
Adjustments to reconcile net income (loss) to net cash
provided by operating activities: |
||||||||
Loss on sale of Savvi business |
| 4,286 | ||||||
Depreciation and amortization |
3,845 | 5,167 | ||||||
Provision for inventory obsolescence reserves |
1,501 | 2,757 | ||||||
Non-cash restructuring (adjustments) charges |
(858 | ) | | |||||
Non-cash interest expense |
216 | 140 | ||||||
Non-cash amortization of premium on investments |
912 | 1,194 | ||||||
Loss on disposal of property and equipment |
3 | | ||||||
Loss (gain) on early extinguishments of convertible
subordinated notes |
387 | (825 | ) | |||||
Deferred income taxes |
572 | 265 | ||||||
Loss on disposal of fixed assets |
| 492 | ||||||
Stock-based compensation expense |
533 | | ||||||
Tax benefit of stock-based benefit plans |
1,720 | | ||||||
Other |
(114 | ) | 263 | |||||
Changes in operating assets and liabilities: |
||||||||
Accounts receivable |
(5,747 | ) | (2,033 | ) | ||||
Other receivables |
(2,600 | ) | 16 | |||||
Inventories |
2,891 | (5,183 | ) | |||||
Other current assets |
130 | 1,869 | ||||||
Accounts payable |
4,296 | (1,403 | ) | |||||
Accrued restructuring |
(1,647 | ) | (1,305 | ) | ||||
Accrued interest payable |
502 | (223 | ) | |||||
Accrued wages and bonuses |
(1,199 | ) | (601 | ) | ||||
Other accrued liabilities |
(835 | ) | 1,763 | |||||
Net cash provided by operating activities |
10,863 | 4,182 | ||||||
Cash flows from investing activities: |
||||||||
Proceeds from sale or maturity of held-to-maturity
investments |
31,130 | 53,801 | ||||||
Purchase of held-to-maturity investments |
(18,645 | ) | (52,479 | ) | ||||
Capital expenditures |
(2,148 | ) | (1,084 | ) | ||||
Proceeds from the sale of Savvi business |
| 360 | ||||||
Net cash provided by investing activities |
10,337 | 598 | ||||||
Cash flows from financing activities: |
||||||||
Early extinguishments of convertible subordinated notes |
(58,168 | ) | (9,238 | ) | ||||
Borrowings under revolving line of credit |
13,000 | | ||||||
Repayments on revolving line of credit |
(13,000 | ) | | |||||
Principal payments on mortgage payable |
| (44 | ) | |||||
Proceeds from issuance of common stock |
6,717 | 1,334 | ||||||
Net cash used in financing activities |
(51,451 | ) | (7,948 | ) | ||||
Effects of exchange rate changes |
(367 | ) | 730 | |||||
Net decrease in cash and cash equivalents |
(30,618 | ) | (2,438 | ) | ||||
Cash and cash equivalents, beginning of period |
149,925 | 33,138 | ||||||
Cash and cash equivalents, end of period |
$ | 119,307 | $ | 30,700 | ||||
The accompanying notes are an integral part of these financial statements.
5
RADISYS CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note 1 Significant Accounting Policies
RadiSys Corporation (the Company) has adhered to the accounting policies set forth in its Annual Report on Form 10-K for the year ended December 31, 2003 in preparing the accompanying interim Consolidated Financial Statements. The preparation of these statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosure of contingent assets and liabilities. Actual results could differ from those estimates.
The financial information included herein reflects all normal recurring adjustments that are, in the opinion of management, necessary for a fair presentation of the results for interim periods.
For the three and six month periods ended June 30, 2004, there have been no changes to these accounting policies.
Reclassifications
Certain reclassifications have been made to amounts in prior years to conform to current year presentation. These changes had no effect on previously reported results of operations or shareholders equity.
Accrued Restructuring
In July 2002, the Financial Accounting Standard Board (FASB) issued Statement of Financial Accounting Standard (SFAS) No. 146 Accounting for Costs Associated with Exit or Disposal Activities. SFAS No. 146 requires that liabilities for costs associated with exit or disposal activities be recognized and measured initially at fair value in the period in which the liabilities are incurred. For the year ended December 31, 2003, the Company recorded restructuring charges in accordance with the provisions of SFAS No. 146.
Prior to the year ended December 31, 2003, the Company recorded restructuring charges including employee termination and related costs, costs related to leased facilities, losses on impairment of fixed assets and capitalized software and other accounting and legal fees. Employee termination and related costs were previously recorded in accordance with the provisions of Emerging Issues Task Force No. 94-3, Liability Recognition for Certain Employee Termination Benefits and Other Costs to Exit an Activity. For leased facilities that were vacated and subleased, an amount equal to the total future lease obligations from the date of vacating the premises through the expiration of the lease, net of any future sublease income, was recorded as a part of restructuring charges.
Warranty
The Company provides for the estimated cost of product warranties at the time it recognizes revenue. Products are generally sold with warranty coverage for a period of 24 months after shipment. Parts and labor are covered under the terms of the warranty agreement. The warranty provision is based on historical experience by product family. The Company engages in extensive product quality programs and processes, including actively monitoring and evaluating the quality of its components suppliers; however, ongoing failure rates, material usage and service delivery costs incurred in correcting product failure, as well as specific product class failures out of the Companys baseline experience affect the estimated warranty obligation. If actual product failure rates, material usage or service delivery costs differ from estimates, revisions to the estimated warranty liability would be required.
6
The following is a summary of the change in the Companys warranty liability for the six months ended June 30, 2004 and 2003 (in thousands):
| For the Six Months Ended | ||||||||
| June 30, |
||||||||
| 2004 |
2003 |
|||||||
Warranty liability balance, beginning of the period |
$ | 2,276 | $ | 1,553 | ||||
Product warranty accruals |
951 | 2,029 | ||||||
Adjustments for payments made |
(1,639 | ) | (1,322 | ) | ||||
Warranty liability balance, end of the period |
$ | 1,588 | $ | 2,260 | ||||
The warranty liability balance is included in other accrued liabilities in the accompanying Consolidated Balance Sheets as of June 30, 2004 and December 31, 2003. The Company offers fixed price support or maintenance contracts to its customers. Revenues from fixed price support or maintenance contracts were not significant to the Companys operations for the periods reported.
Stock-based Compensation
The Company accounts for its stock-based compensation plans using the intrinsic value method and provides pro forma disclosures of net income (loss) and net income (loss) per common share as if the fair value method had been applied in measuring compensation expense. Equity instruments are granted to employees, directors, and consultants in certain instances, as defined in the respective plan agreements.
Had RadiSys accounted for these plans under the fair value method, the Companys net income (loss) and pro forma net income (loss) per share would have been reported as follows (in thousands, except per share amounts):
| For the Three Months Ended | For the Six Months Ended | |||||||||||||||
| June 30, |
June 30, |
|||||||||||||||
| 2004 |
2003 |
2004 |
2003 |
|||||||||||||
Net income (loss) |
$ | 3,507 | $ | 1,789 | $ | 6,355 | $ | (2,457 | ) | |||||||
Add: Stock-based
compensation expense
included in reported net
income (loss), net of
related tax effects |
220 | | 329 | | ||||||||||||
Deduct: Stock-based
compensation expense
determined under fair
value method for all
awards, net of related tax
effects |
(2,015 | ) | (1,762 | ) | (3,453 | ) | (2,792 | ) | ||||||||
Pro forma net income (loss). |
$ | 1,712 | $ | 27 | $ | 3,231 | $ | (5,249 | ) | |||||||
Net income (loss) per share: |
||||||||||||||||
Basic |
$ | 0.19 | $ | 0.10 | $ | 0.34 | $ | (0.14 | ) | |||||||
Diluted |
$ | 0.18 | $ | 0.10 | $ | 0.33 | $ | (0.14 | ) | |||||||
Pro forma basic |
$ | 0.09 | $ | 0.00 | $ | 0.17 | $ | (0.30 | ) | |||||||
Pro forma diluted |
$ | 0.09 | $ | 0.00 | $ | 0.17 | $ | (0.30 | ) | |||||||
During the three and six month periods ended June 30, 2004, the Company incurred $356 thousand and $533 thousand of stock-based compensation expense, respectively. The stock-based compensation expense was associated with shares issued and to be issued pursuant to the Companys 1996 Employee Stock Purchase Plan (ESPP). The Company incurred stock-based compensation expense because the original number of ESPP shares approved by the shareholders will be insufficient to meet employee demand for an ESPP offering which was consummated in February 2003 and ends in August 2004. The Company subsequently received shareholder approval for additional ESPP shares in May 2003. The shares issued and to be issued in the February 2003 ESPP offering in excess of the original number of ESPP shares approved at the beginning of the offering (the shortfall) triggers recognition of stock-based compensation expense under the intrinsic value method. The shortfall amounted to 138 thousand shares in May 2004 and the Company currently estimates the shortfall to amount to 152 thousand shares to be issued in August 2004.
7
The expense per share is calculated as the difference between 85% of the closing price of RadiSys shares as quoted on NASDAQ on the date that additional ESPP shares were approved (May 2003) and the February 2003 ESPP offering purchase price. Accordingly, the expense per share is calculated as the difference between $8.42 and $5.48. The shortfall of shares is dependent on the amount of contributions from participants enrolled in the February 2003 ESPP offering.
The Company recognized stock-based compensation expense as follows (in thousands):
| For the Three Months Ended | For the Six Months Ended | |||||||||||||||
| June 30, |
June 30, |
|||||||||||||||
| 2004 |
2003 |
2004 |
2003 |
|||||||||||||
Cost of sales |
$ | 34 | $ | | $ | 81 | $ | | ||||||||
Research and development |
177 | | 251 | | ||||||||||||
Selling, general and administrative |
145 | | 201 | | ||||||||||||
| $ | 356 | $ | $ | 533 | $ | |||||||||||
For the three months ended September 30, 2004 and the three months ended December 31, 2004, the Company estimates stock-based compensation expense recognized under the intrinsic value method to amount to approximately $275 thousand and $50 thousand, respectively. Approximately $114 thousand, $90 thousand, and $71 thousand of the stock-based compensation expense currently expected to be incurred in the third quarter of 2004 is associated with cost of sales, research and development, and selling, general and administrative expenses, respectively. Approximately $50 thousand of stock-based compensation currently expected to be incurred in the fourth quarter of 2004 is associated with cost of sales. After the fourth quarter of 2004, the Company currently does not anticipate incurring stock-based compensation expense associated with the Companys ESPP.
Recent Accounting Pronouncements
In March 2004, the Emerging Issues Task Force (EITF) reached a consensus on Issue 03-1, The Meaning of Other-Than-Temporary Impairment and its Application to Certain Investments. EITF No. 03-01 requires disclosures on investments in an unrealized loss position. The disclosures are designed to help financial statement users analyze a companys unrealized losses on its investments and to enable them to better understand the basis for any management conclusion that the impairment is temporary. Quantitative and qualitative disclosures for investments accounted for under FASB Statement No. 115, Accounting for Certain Investments in Debt and Equity Securities, are effective for the first annual reporting period ending after December 15, 2003. All new disclosures related to cost method investments are effective for the annual reporting periods ending after June 15, 2004. Comparative information for the periods prior to the period of initial application is not required. The Company does not believe that EITF 03-1 will have a material impact on its financial position, results of operations or cash flows.
8
In June 2004, the EITF issued a draft of EITF No. 04-08, Accounting Issues Related to Certain Features of Contingently Convertible Debt and the Effect on Diluted Earnings per Share. EITF No 04-08 proposes that companies should not exclude shares underlying a convertible bond through the use of a contingent conversion or CoCo feature. If ratified by Financial Accounting Standards Board (FASB), the proposal would be applied retroactively, which would require companies to restate diluted earnings per share by applying the If-Converted method of accounting from the issuance date of the convertible bond. The following table depicts the effect of the EITF as currently drafted, if the EITF is ratified by the FASB (in thousands, except per share amounts).
| For the Three | For the Three | For the Six | ||||||||||
| Months Ended | Months Ended | Months Ended | ||||||||||
| March 31, 2004 |
June 30, 2004 |
June 30, 2004 |
||||||||||
Net income, diluted, as reported |
$ | 2,848 | $ | 3,507 | $ | 6,355 | ||||||
Interest on convertible notes, net of tax benefit |
300 | 282 | 582 | |||||||||
Net income, diluted, as adjusted |
$ | 3,148 | $ | 3,789 | $ | 6,937 | ||||||
Weighted average shares used to calculate net income
per share, diluted, as reported |
19,447 | 19,590 | 19,522 | |||||||||
Effect of Convertible Senior Notes |
4,243 | 4,243 | 4,243 | |||||||||
Weighted average shares used to calculate net income
per share, diluted, as adjusted |
23,690 | 23,833 | 23,765 | |||||||||
Net income per share, diluted: |
||||||||||||
As reported |
$ | 0.15 | $ | 0.18 | $ | 0.33 | ||||||
As adjusted |
$ | 0.13 | $ | 0.16 | $ | 0.29 | ||||||
Note 2 Held-to-maturity Investments
Held-to-maturity investments consisted of the following (in thousands):
| June 30, | December 31, | |||||||
| 2004 |
2003 |
|||||||
Short-term held-to-maturity investments,
including unamortized premium of $443 and
$767, respectively |
$ | 26,201 | $ | 44,456 | ||||
Long-term held-to-maturity investments,
including unamortized premium of none and
$442, respectively |
$ | 35,850 | $ | 30,992 | ||||
The Company invests excess cash in debt instruments of the U.S. Government and its agencies and those of high-quality corporate issuers. As of June 30, 2004, the Companys long-term held-to-maturity investments had maturities ranging from 15.7 months to 35.6 months. The Companys investment policy requires that the total investment portfolio, including cash and investments, not exceed a maximum weighted-average maturity of 18 months. In addition, the policy mandates that an individual investment must have a maturity of less than 36 months, with no more than 20% of the total portfolio exceeding 24 months. As of June 30, 2004, the Company was in compliance with its investment policy.
Note 3 Accounts Receivable and Other Receivables
Accounts receivable consists of